Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 437

1.

Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.

Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, Calhoun V, Cannon D, Carr V, Catts S, Chen J, Chen JX, Chen X, Chiapponi C, Cho KK, Ciullo V, Corvin AS, Crespo-Facorro B, Cropley V, De Rossi P, Diaz-Caneja CM, Dickie EW, Ehrlich S, Fan FM, Faskowitz J, Fatouros-Bergman H, Flyckt L, Ford JM, Fouche JP, Fukunaga M, Gill M, Glahn DC, Gollub R, Goudzwaard ED, Guo H, Gur RE, Gur RC, Gurholt TP, Hashimoto R, Hatton SN, Henskens FA, Hibar DP, Hickie IB, Hong LE, Horacek J, Howells FM, Hulshoff Pol HE, Hyde CL, Isaev D, Jablensky A, Jansen PR, Janssen J, Jönsson EG, Jung LA, Kahn RS, Kikinis Z, Liu K, Klauser P, Knöchel C, Kubicki M, Lagopoulos J, Langen C, Lawrie S, Lenroot RK, Lim KO, Lopez-Jaramillo C, Lyall A, Magnotta V, Mandl RCW, Mathalon DH, McCarley RW, McCarthy-Jones S, McDonald C, McEwen S, McIntosh A, Melicher T, Mesholam-Gately RI, Michie PT, Mowry B, Mueller BA, Newell DT, O'Donnell P, Oertel-Knöchel V, Oestreich L, Paciga SA, Pantelis C, Pasternak O, Pearlson G, Pellicano GR, Pereira A, Pineda Zapata J, Piras F, Potkin SG, Preda A, Rasser PE, Roalf DR, Roiz R, Roos A, Rotenberg D, Satterthwaite TD, Savadjiev P, Schall U, Scott RJ, Seal ML, Seidman LJ, Shannon Weickert C, Whelan CD, Shenton ME, Kwon JS, Spalletta G, Spaniel F, Sprooten E, Stäblein M, Stein DJ, Sundram S, Tan Y, Tan S, Tang S, Temmingh HS, Westlye LT, Tønnesen S, Tordesillas-Gutierrez D, Doan NT, Vaidya J, van Haren NEM, Vargas CD, Vecchio D, Velakoulis D, Voineskos A, Voyvodic JQ, Wang Z, Wan P, Wei D, Weickert TW, Whalley H, White T, Whitford TJ, Wojcik JD, Xiang H, Xie Z, Yamamori H, Yang F, Yao N, Zhang G, Zhao J, van Erp TGM, Turner J, Thompson PM, Donohoe G.

Mol Psychiatry. 2017 Oct 17. doi: 10.1038/mp.2017.170. [Epub ahead of print]

PMID:
29038599
2.

Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups.

Woods SW, Powers AR 3rd, Taylor JH, Davidson CA, Johannesen JK, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH.

Schizophr Bull. 2017 Sep 28. doi: 10.1093/schbul/sbx138. [Epub ahead of print]

PMID:
29036402
3.

The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project.

Blokland GAM, Del Re EC, Mesholam-Gately RI, Jovicich J, Trampush JW, Keshavan MS, DeLisi LE, Walters JTR, Turner JA, Malhotra AK, Lencz T, Shenton ME, Voineskos AN, Rujescu D, Giegling I, Kahn RS, Roffman JL, Holt DJ, Ehrlich S, Kikinis Z, Dazzan P, Murray RM, Di Forti M, Lee J, Sim K, Lam M, Wolthusen RPF, de Zwarte SMC, Walton E, Cosgrove D, Kelly S, Maleki N, Osiecki L, Picchioni MM, Bramon E, Russo M, David AS, Mondelli V, Reinders AATS, Falcone MA, Hartmann AM, Konte B, Morris DW, Gill M, Corvin AP, Cahn W, Ho NF, Liu JJ, Keefe RSE, Gollub RL, Manoach DS, Calhoun VD, Schulz SC, Sponheim SR, Goff DC, Buka SL, Cherkerzian S, Thermenos HW, Kubicki M, Nestor PG, Dickie EW, Vassos E, Ciufolini S, Reis Marques T, Crossley NA, Purcell SM, Smoller JW, van Haren NEM, Toulopoulou T, Donohoe G, Goldstein JM, Seidman LJ, McCarley RW, Petryshen TL.

Schizophr Res. 2017 Oct 3. pii: S0920-9964(17)30586-8. doi: 10.1016/j.schres.2017.09.024. [Epub ahead of print]

PMID:
28982554
4.

Exploration of clinical high-risk dropouts.

Stowkowy J, Liu L, Cadenhead KS, Tsuang MT, Cannon TD, Cornblatt BA, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Walker EF, Bearden CE, Mathalon DH, Addington J.

Schizophr Res. 2017 Sep 27. pii: S0920-9964(17)30573-X. doi: 10.1016/j.schres.2017.09.018. [Epub ahead of print] No abstract available.

PMID:
28964651
5.

Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety.

Lu Y, Marshall C, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J.

Psychiatry Res. 2017 Aug 31. pii: S0165-1781(17)30315-3. doi: 10.1016/j.psychres.2017.08.045. [Epub ahead of print]

PMID:
28886901
6.

Suppression of irrelevant sounds during auditory working memory.

Ahveninen J, Seidman LJ, Chang WT, Hämäläinen M, Huang S.

Neuroimage. 2017 Aug 14;161:1-8. doi: 10.1016/j.neuroimage.2017.08.040. [Epub ahead of print]

PMID:
28818692
7.

Abnormal relationships between local and global brain measures in subjects at clinical high risk for psychosis: a pilot study.

Konishi J, Del Re EC, Bouix S, Blokland GAM, Mesholam-Gately R, Woodberry K, Niznikiewicz M, Goldstein J, Hirayasu Y, Petryshen TL, Seidman LJ, Shenton ME, McCarley RW.

Brain Imaging Behav. 2017 Aug 16. doi: 10.1007/s11682-017-9758-z. [Epub ahead of print]

PMID:
28815390
8.

The role of a family history of psychosis for youth at clinical high risk of psychosis.

Georgopoulos G, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J.

Early Interv Psychiatry. 2017 Aug 9. doi: 10.1111/eip.12471. [Epub ahead of print]

PMID:
28792113
9.

Cross-Disorder Cognitive Impairments in Youth Referred for Neuropsychiatric Evaluation.

Doyle AE, Vuijk PJ, Doty ND, McGrath LM, Willoughby BL, O'Donnell EH, Wilson HK, Colvin MK, Toner DC, Hudson KE, Blais JE, Ditmars HL, Faraone SV, Seidman LJ, Braaten EB.

J Int Neuropsychol Soc. 2017 Aug 4:1-13. doi: 10.1017/S1355617717000601. [Epub ahead of print]

PMID:
28774351
10.

Changes in symptom content from a clinical high-risk state to conversion to psychosis.

Marshall C, Lu Y, Lyngberg K, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J.

Early Interv Psychiatry. 2017 Aug 3. doi: 10.1111/eip.12473. [Epub ahead of print]

PMID:
28771938
11.

Neural - hormonal responses to negative affective stimuli: Impact of dysphoric mood and sex.

Mareckova K, Holsen L, Admon R, Whitfield-Gabrieli S, Seidman LJ, Buka SL, Klibanski A, Goldstein JM.

J Affect Disord. 2017 Nov;222:88-97. doi: 10.1016/j.jad.2017.06.050. Epub 2017 Jun 28.

PMID:
28688266
12.

Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort.

Kline ER, Seidman LJ, Cornblatt BA, Woodberry KA, Bryant C, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Addington J.

Schizophr Res. 2017 Jun 1. pii: S0920-9964(17)30307-9. doi: 10.1016/j.schres.2017.05.032. [Epub ahead of print]

PMID:
28578922
13.

Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension.

Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.

Schizophr Res. 2017 May 23. pii: S0920-9964(17)30272-4. doi: 10.1016/j.schres.2017.05.013. [Epub ahead of print]

PMID:
28549722
14.

Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis.

Velthorst E, Zinberg J, Addington J, Cadenhead KS, Cannon TD, Carrión RE, Auther A, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Reichenberg A, Bearden CE.

Dev Psychopathol. 2017 Apr 19:1-9. doi: 10.1017/S0954579417000451. [Epub ahead of print]

PMID:
28420458
15.

Comorbid diagnoses for youth at clinical high risk of psychosis.

Addington J, Piskulic D, Liu L, Lockwood J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW.

Schizophr Res. 2017 Mar 31. pii: S0920-9964(17)30183-4. doi: 10.1016/j.schres.2017.03.043. [Epub ahead of print]

PMID:
28372906
16.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.

McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH; Project MinE GWAS Consortium; Schizophrenia Working Group of the Psychiatric Genomics Consortium.

Nat Commun. 2017 Mar 21;8:14774. doi: 10.1038/ncomms14774.

17.

Adapting cognitive remediation to a group home: A brief report.

Schutt RK, Seidman LJ, Eack SM, Deck B, Keshavan MS.

Asian J Psychiatr. 2017 Feb;25:184-187. doi: 10.1016/j.ajp.2016.11.003. Epub 2016 Nov 11.

PMID:
28262146
18.

Impaired white matter connectivity between regions containing mirror neurons, and relationship to negative symptoms and social cognition, in patients with first-episode schizophrenia.

Saito Y, Kubicki M, Koerte I, Otsuka T, Rathi Y, Pasternak O, Bouix S, Eckbo R, Kikinis Z, von Hohenberg CC, Roppongi T, Del Re E, Asami T, Lee SH, Karmacharya S, Mesholam-Gately RI, Seidman LJ, Levitt J, McCarley RW, Shenton ME, Niznikiewicz MA.

Brain Imaging Behav. 2017 Feb 28. doi: 10.1007/s11682-017-9685-z. [Epub ahead of print]

PMID:
28247157
19.

Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis.

Chung Y, Haut KM, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Cannon TD; North American Prodrome Longitudinal Study (NAPLS) Consortium.

Schizophr Res. 2017 Feb 25. pii: S0920-9964(17)30100-7. doi: 10.1016/j.schres.2017.02.014. [Epub ahead of print]

PMID:
28245961
20.

Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis.

Hoogman M, Bralten J, Hibar DP, Mennes M, Zwiers MP, Schweren LSJ, van Hulzen KJE, Medland SE, Shumskaya E, Jahanshad N, Zeeuw P, Szekely E, Sudre G, Wolfers T, Onnink AMH, Dammers JT, Mostert JC, Vives-Gilabert Y, Kohls G, Oberwelland E, Seitz J, Schulte-Rüther M, Ambrosino S, Doyle AE, Høvik MF, Dramsdahl M, Tamm L, van Erp TGM, Dale A, Schork A, Conzelmann A, Zierhut K, Baur R, McCarthy H, Yoncheva YN, Cubillo A, Chantiluke K, Mehta MA, Paloyelis Y, Hohmann S, Baumeister S, Bramati I, Mattos P, Tovar-Moll F, Douglas P, Banaschewski T, Brandeis D, Kuntsi J, Asherson P, Rubia K, Kelly C, Martino AD, Milham MP, Castellanos FX, Frodl T, Zentis M, Lesch KP, Reif A, Pauli P, Jernigan TL, Haavik J, Plessen KJ, Lundervold AJ, Hugdahl K, Seidman LJ, Biederman J, Rommelse N, Heslenfeld DJ, Hartman CA, Hoekstra PJ, Oosterlaan J, Polier GV, Konrad K, Vilarroya O, Ramos-Quiroga JA, Soliva JC, Durston S, Buitelaar JK, Faraone SV, Shaw P, Thompson PM, Franke B.

Lancet Psychiatry. 2017 Apr;4(4):310-319. doi: 10.1016/S2215-0366(17)30049-4. Epub 2017 Feb 16.

PMID:
28219628

Supplemental Content

Loading ...
Support Center